--- title: CDMOs offering Sterile Fill-Finish & Aseptic Manufacturing with Biologics (Other) path: /explore/sterile-fill-finish/biologics-other companies_count: 46 --- # CDMOs offering Sterile Fill-Finish & Aseptic Manufacturing with Biologics (Other) 46 published CDMOs match Sterile Fill-Finish & Aseptic Manufacturing and Biologics (Other). Locations in this set include United States, China, Germany, India, Italy, and United Kingdom. Capabilities that show up most often in this set: CMC Analytical Development, Quality Control Testing, Technology Transfer, CMC Regulatory Submission Support, and Formulation Development. ## Matching companies - [AGC Biologics](/companies/agcbio) - Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. - [AbbVie Contract Manufacturing](/companies/abbviecontractmfg) - Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe. - [Aenova Group](/companies/aenova-group) - Aenova Group is a worldwide leading contract manufacturer for the pharmaceutical and healthcare industry, offering solid dosage, sterile, semi-solid, and softgel manufacturing across multiple European and North American facilities. - [Akron Bio](/companies/akronbiotech) - Akron Bio manufactures cGMP-compliant recombinant proteins, media, buffers, and transfection reagents for cell and gene therapy companies. Services span process development, fill-finish, and custom ancillary product manufacturing. - [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Ardena](/companies/ardena) - Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances. - [Argonaut Manufacturing Services](/companies/argonautms) - Argonaut is a sterile fill-finish CDMO specializing in isolator-based aseptic manufacturing for biologics, peptides, nucleic acids, lipid nanoparticles, gene therapies, and vaccines from preclinical through commercial scale, with FDA and Annex 1 compliance. - [Ascendia Pharmaceutical Solutions](/companies/ascendiacdmo) - Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol. - [Asymchem Laboratories](/companies/asymchem) - Asymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry. - [BSP Pharmaceuticals](/companies/bsppharmaceuticals) - BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply. - [Boston Institute of Biotechnology, LLC](/companies/bostonbib) - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. - [Burrard Pharmaceuticals](/companies/burrardpharma) - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005. - [CDMO Network](/companies/cdmonetwork) - CDMO Network is a biomanufacturing partner-routing platform that connects biotech sponsors with specialized CDMO partners across modalities, development stages, and geographies to reduce integration friction and accelerate program execution. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [CordenPharma](/companies/cordenpharma) - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees. - [Curia](/companies/curiaglobal) - Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India. - [Delpharm](/companies/delpharm) - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually. - [Dr. Reddy's Laboratories](/companies/drreddys) - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.